Skip to main navigation
Advancing Diagnostics to Improve Cancer Treatments Navigation
  • Products
  • Technology
  • Partnership Opportunities
  • Company
  • Contact

Investor Relations

Investor Relations

  • Overview
  • Press Releases
  • Events & Presentations
  • Financial Information
  • Stock Information
  • Corporate Governance
  • Investor FAQs
  • Contact Us

Shareholder Tools

  • Email Alerts Subscription
  • Download Library
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter
  • RSS

SEC Filing Details

Document Details

Form
10-Q
Filing Date
May 23, 2022
Document Date
Mar 31, 2022
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Biocept Inc.
Issuer
BIOCEPT INC

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT
Investor Relations Company Careers Customer Service
Contact Biocept, Inc.

Biocept, Inc. Headquarters
9955 Mesa Rim Road
San Diego, CA 92121
Phone: 858.320.8200
Fax: 858.320.8225
Email: IR@biocept.com

LHA Investor Relations
Jody Cain
310.691.7107
jcain@lhai.com


  • Careers
  • Company
  • Technology
  • Privacy Policy
  • Terms of Use
  • Contact Us

© 2023 Biocept, Inc. All rights reserved.